(2-Benzyloxy-ethyl)-isopropyl-amine | 768357-96-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2-Benzyloxy-ethyl)-isopropyl-amine
• 英文别名: N-(2-(Benzyloxy)ethyl)propan-2-amine；N-(2-phenylmethoxyethyl)propan-2-amine
• CAS: 768357-96-6
• 化学式: C₁₂H₁₉NO
• 分子量: 193.289
• InChiKey: AFTHGBHRPYZHJI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  21.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (2-Benzyloxy-ethyl)-isopropyl-amine 在 sodium hydroxide 、 lithium aluminium tetrahydride 、 TEA 、 N,N-二异丙基乙胺 、 N,N'-羰基二咪唑 作用下， 以 四氢呋喃 、 甲醇 、 甲苯 为溶剂， 生成 (S)-1-(2-(benzyloxy)ethyl)-1-isopropyl-3-(1-oxo-3-phenylpropan-2-yl)urea
  参考文献：
  名称：

  A novel series of urea-based peptidomimetic calpain inhibitors

  摘要：

  A series of peptide aldehyde derivatives in which the P-2 chiral carbon has been replaced with nitrogen were synthesized as urea-based peptidomimetic inhibitors of mu-calpain. The compounds mirrored the general SAR of peptidyl aldehyde calpain inhibitors but displayed greater selectivity for mu-calpain over cathepsin B. (C) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.12.068
• 作为产物：
  描述：

  2-苄基-1-乙胺 、 丙酮 在 溶剂黄146 、 三乙酰氧基硼氢化钠 作用下， 以 二氯甲烷 为溶剂， 反应 1.33h， 以90 mg的产率得到(2-Benzyloxy-ethyl)-isopropyl-amine
  参考文献：
  名称：

  BENZODICYCLOALKANE DERIVATIVE, PREPARATION METHOD AND USE THEREOF

  摘要：

  本文提供了一种苯并螺环烷衍生物，以及其制备方法和用途。具体而言，本文提供了一种式（I）化合物，或其药用可接受的盐、立体异构体或溶剂化合物，以及其制备方法，并用于制备治疗疼痛药物的用途。

  公开号：

  US20190161468A1

文献信息

• NEW IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4
  申请人：Perha Pharmaceuticals

  公开号：EP3904354A1

  公开（公告）日：2021-11-03

  The present invention relates to a compound of formula (I) wherein R1 represents a (C1-C6)alkyl group, a spiro(C5-C11)bicyclic ring, a fused phenyl group, a substituted phenyl group, a R'-L- group, wherein L is either a single bond or a (Ci-C3)alkanediyl group, and R' represents a (C3-C8)cycloalkyl group, a bridged (C6-C10)cycloalkyl group, a (C3-C8)heterocycloalkyl group, or a (C3-C8)heteroaryl group, or a R'-L- group wherein L is a (Ci-C3)alkanediyl group, and R' is a an optionally substituted phenyl group or any of its pharmaceutically acceptable salt. The present invention further relates to a composition comprising a compound of formula (I) and a process for manufacturing said compound as well as its synthesis intermediates. It also relates to said compound for use as a medicament, in particular in the treatment and/or prevention of cognitive deficits associated with Down syndrome; Alzheimer's disease; dementia; tauopathies; Parkinson's disease; CDKL5 Deficiency Disorder; Phelan-McDermid syndrome; autism; diabetes; regulation of folate and methionine metabolism; osteoarthritis; Duchenne muscular dystrophy; several cancers; neuroinflammation, anemia and infections and for regulating body temperature.

  本发明涉及一种化合物，其化学式为（I），其中R1代表（C1-C6）烷基基团，螺环（C5-C11）双环环，融合苯基团，取代苯基团，R'-L-基团，其中L是一个单键或（Ci-C3）烷二基基团，而R'代表（C3-C8）环烷基团，桥接（C6-C10）环烷基团，（C3-C8）杂环烷基团，或（C3-C8）杂芳基团，或者R'-L-基团，其中L是一个（Ci-C3）烷二基基团，而R'是一个可选择取代的苯基团或其任何药用盐。本发明还涉及包含化合物（I）的组合物，以及制造所述化合物的方法以及其合成中间体。它还涉及所述化合物用作药物，特别是用于治疗和/或预防与唐氏综合症、阿尔茨海默病、痴呆症、tau蛋白病、帕金森病、CDKL5缺陷症、菲兰-麦克德米德综合症、自闭症、糖尿病、叶酸和蛋氨酸代谢调节、骨关节炎、杜兴氏肌营养不良、多种癌症、神经炎症、贫血和感染以及体温调节相关的认知缺陷。
• Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative
  申请人：SANTEN PHARMACEUTICAL CO., LTD.

  公开号：EP2042173A2

  公开（公告）日：2009-04-01

  The present invention provides κ opioid receptor agonists comprising 2-phenylbenzothiazoline derivatives. The present invention relates to κ opioid receptor agonists comprising compounds or salts thereof having the chemical structure represented by the general formula [I]. Namely, it is important for exhibition of the κ opioid receptor agonist actions to have an alkyl group having an amino group at a phenyl group of 2-phenylbenzothiazoline as a substituent and to have an acyl group at a nitrogen atom of 2-phenylbenzothiazoline, wherein R is alkyl having the amino group as the substituent; and R1 is acyl.

  本发明提供了由 2-苯基苯并噻唑啉衍生物组成的 κ 阿片受体激动剂。本发明涉及由具有通式[I]所代表的化学结构的化合物或其盐组成的κ阿片受体激动剂。也就是说，对于展示κ阿片受体激动剂的作用来说，重要的是在2-苯基苯并噻唑啉的苯基上具有氨基的烷基作为取代基，并且在2-苯基苯并噻唑啉的氮原子上具有酰基、 其中 R 是以氨基为取代基的烷基；R1 是酰基。
• Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereof
  申请人：SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.

  公开号：US10577346B2

  公开（公告）日：2020-03-03

  It is provided herein a benzobicycloalkane derivative, and a preparation method and use thereof. In particular, it is provided herein a compound of Formula (I), or a pharmaceutically acceptable salt, stereoisomer or solvate thereof, a preparation method, and a use thereof in preparation of drugs for treating pain.

  本文提供了一种苯并双环烷烃衍生物及其制备方法和用途。特别是提供了一种式（I）化合物或其药学上可接受的盐、立体异构体或溶解物、制备方法及其在制备治疗疼痛药物中的用途。
• Kappa-opioid receptor agonist comprising a 2-phenylbenzothiazoline derivative
  申请人：SANTEN PHARMACEUTICAL CO., LTD.

  公开号：EP1496053B1

  公开（公告）日：2012-06-20
• US7410987B2
  申请人：——

  公开号：US7410987B2

  公开（公告）日：2008-08-12